NCT01635738 - Probiotics and Allergic Diseases | Biotech Hunter

Enrollment

240

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

June 30, 2014

Study Completion Date

June 30, 2014

Conditions

Atopic DermatitisAsthma

Interventions

BIOLOGICAL

LP GMNL-133 capsule

One capsule with 2x10\^9 (cfu) LP GMNL-133, once daily, PO

BIOLOGICAL

LF GM-090 capsule

Arm: LF GM-090 group One capsule with 2x10\^9 (cfu) LF GM-090, once daily, PO

BIOLOGICAL

LP GMNL-133 +LF GM-090 capsule

One capsule with 4x10\^9 (cfu) LP GMNL-133 +LF GM-090, once daily, PO

BIOLOGICAL

Placebo

Trial Locations (1)

Taipei Hospital, Department of Health, Taiwan, R.O.C., New Taipei City

All Listed Sponsors

collaborator

National Science and Technology Council, Taiwan

OTHER_GOV

lead

GenMont Biotech Incorporation

INDUSTRY